Cipla Q3 Results: Pharma major Cipla posted a massive 57% YoY fall in net profit as production halt at Lanreotide manufacturing facility along with the one-time expense due to new labour codes, impacted the bottomline of the company.
Cipla Q3 Results: Pharma major Cipla posted a massive 57% YoY fall in net profit as production halt at Lanreotide manufacturing facility along with the one-time expense due to new labour codes, impacted the bottomline of the company.